The Antioxidant Anethole Dithiolethione Inhibits Monoamine Oxidase-B but Not Monoamine Oxidase A Activity in Extracts of Cultured Astrocytes
Overview
Physiology
Affiliations
Anethole dithiolethione (ADT) is a clinically available, pluripotent antioxidant proposed as a neuroprotectant for Parkinson's disease (PD). Here, using extracts from cultured astrocytes, containing both monoamine oxidase (MAO) A and B activity, we demonstrate that ADT concentration-dependently inhibits MAO-B activity in a clinically relevant concentration range (0.03-30 microM, IC-50 = 0.5 microM) without affecting MAO A activity. Considering the alleged contribution of MAO activity in general, and MAO-B in particular, to oxidative stress and neurodegeneration in PD, our data further support the neuroprotective potential of ADT.
Vastegani S, Khoshnam S, Ghafouri S, Bakhtiari N, Farbood Y, Sarkaki A PLoS One. 2023; 18(11):e0294612.
PMID: 37972114 PMC: 10653401. DOI: 10.1371/journal.pone.0294612.
Vastegani S, Khoshnam S, Mansouri E, Ghafouri S, Bakhtiari N, Farbood Y Metab Brain Dis. 2023; 38(6):2159-2174.
PMID: 37204660 DOI: 10.1007/s11011-023-01230-6.
mTOR and ROS regulation by anethole on adipogenic differentiation in human mesenchymal stem cells.
Rhee Y, Moon J, Mo J, Pham T, Chung P BMC Cell Biol. 2018; 19(1):12.
PMID: 29980168 PMC: 6035441. DOI: 10.1186/s12860-018-0163-2.
Shahamat Z, Abbasi-Maleki S, Mohammadi Motamed S Avicenna J Phytomed. 2016; 6(3):322-8.
PMID: 27462555 PMC: 4930539.
Giustarini D, Fanti P, Sparatore A, Matteucci E, Rossi R Biochem Pharmacol. 2014; 89(2):246-54.
PMID: 24637238 PMC: 4142420. DOI: 10.1016/j.bcp.2014.03.005.